Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study
Óscar Moreno, Mariano Andrés, José‐Manuel León‐Ramírez, José Sánchez–Payá, Juan Carlos Rodrı́guez, Rosario Sánchez‐Martínez, Raquel García Sevila, Vicente Boix, Joan Gil, Esperanza Merino
Topics & Concepts
MedicineTocilizumabInternal medicinePneumoniaCohortRetrospective cohort studyLogistic regressionPneumonia severity indexMechanical ventilationSurgeryCommunity-acquired pneumoniaRheumatoid arthritisCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research